Dr. Nabil F. Saba M.D.
Oncologist | Medical Oncology
1365 Clifton Road Northeast Atlanta Georgia, 30322Rating
4/5
About
My research interest is primarily focused on translational research in upper aerodigestive tract malignancies through discovery of novel agents and novel approaches in treating esophageal and head and neck cancers. Through conducting investigator-initiated clinical trials in primary therapy and the metastatic or recurrent setting, and the conduct of research focusing on biomarker correlative studies, my main goal is to significantly impact clinical care and outcome of patients with upper aerodigestive tumors.
Education and Training
Medical Degree
Govt. Dental College, Bangalore University, India 1990
Board Certification
Internal Medicina
Medical Oncology
Hematology
Internal MedicineAmerican Board of Internal MedicineABIM- 1995
Provider Details
Dr. Nabil F. Saba M.D.'s Expert Contributions
What about the Golo reducing pills for former cancer patients?
I am currently out of the office and will be checking emails sporadiacally. For patient related questions please contact 470 733 4783 during office hours; For non-patient related questions please contact Robin Worthy at 404 778 1436, Nabil F Saba MD, FACP, Professor,Hematology and Medical Oncology, Professor of Otolaryngology, Director of the Head and Neck Oncology Program, Winship Cancer institute of Emory University 1365 Cliffton Rd, C-2110 Atlanta, GA 30322 Phone: 404 778 3995 Fax: 404 778 3995 READ MORE
Expert Publications
Data provided by the National Library of Medicine- Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.
- HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases?
- Advances in Targeting HER3 as an Anticancer Therapy.
- Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.
- Targeted therapies in metastatic esophageal cancer: advances over the past decade.
- Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma.
- Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review.
- Esophagogastric junction and gastric adenocarcinoma: current challenges and future directions.
- Pre-medications for cetuximab induced infusion reactions - commentary.
- Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.
- Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".
- A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma.
- Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.
- Oral Cavity Cancer: Risk Factors, Pathology, and Management.
- Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Clinical Trials
- IRX-2 Regimen, Durvalumab, Tremelimumab for Incurable Head and Neck Squamous Cell Carcinoma
- Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
- Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
- PD 0332991 and Cetuximab in Patients With Incurable SCCHN
Faculty Titles & Positions
- Grand Round Lectures, Gustav Roussy, France, 2009 -
- Grand Rounds, American University of Beirut, 2009 -
Awards
- Castle Connolly Top Doctors, 2011
- Top Docs in Atlanta, 2005
- Recognition for Outstanding Contribution to the Fellowship Program, University of Minnesota, Hematology Oncology and Transplant Section, 2003
- Dean's Honor List , American University of Beirut, 1984-1990
Treatments
- Throat Cancer
- Skin Cancer
- Lung Cancer
- Esophageal Cancer
- Lymphoma
- Oral Cancer
Professional Memberships
- Member International Association of HealthCare Professionals
- Member American College of Physicians
- Member American Society of Clinical Oncology
- Member Massachusetts Medical Society
- Member Emory Healthcare Network Physician
Fellowships
- Princess Margaret Hospital, Toronto, ON, Canada
- Brown University, Providence, RI
- Brown Universities 1997
Treatments
- Head and Neck Cancer and Esophageal Cancer
Internships
- University of Wisconsin
Fellowships
- Brown University, University of Toronto Princess Margaret
Professional Society Memberships
- Discovery and Developmental Therapeutics Research Program, American Association for Cancer Research, The Yul Brynner Head and Neck Cancer Foundation Member, Internal Review Board (IRB) of Emory University, American Society of Hematology, Connective Tissue Oncology Society, American Society of Clinical Oncology,
Professional Affiliations
- Emory University
Articles and Publications
- Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis,
- Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma, Cancer Prevention Research, 2009
- Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug, Head and Neck, 2009
- Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation, Cancer, 2008
What do you attribute your success to?
Perserverance, Excellent Collegues
Areas of research
My work focuses on aero-digestive malignancies, namely head and neck and esophageal cancer, as well as the clinical development of novel agents and therapeutic modalities. I am the principal investigator on several head and neck cancer trials including investigator initiated studies focusing on novel approaches for treating these diseases.
Favorite professional publications
- Head and Neck Journal, Journal of Clinical Oncology
Areas of research
My work focuses on aero-digestive malignancies, namely head and neck and esophageal cancer, as well as the clinical development of novel agents and therapeutic modalities. I am the principal investigator on several head and neck cancer trials including investigator initiated studies focusing on novel approaches for treating these diseases.
Dr. Nabil F. Saba M.D.'s Practice location
ATLANTA, GA 30322Get Direction
Dr. Nabil F. Saba M.D.'s reviews
Write ReviewPatient Experience with Dr. Saba
Recommended Articles
![]()
How to Sort Out Financial Challenges of Breast CancerWhen a woman faces breast cancer, she should only have to worry about one thing: recovery. But the cold hard truth is that many women must face the reality financial hardship during an already tumultuous time. The outcomes of bankruptcy, welfare, and losing the family home are not usually what we...
![]()
What Is Liver Cancer Carcinoma?What Is Carcinoma?When you talk to an Oncologist to inform you on the types of cancer existent at the moment or visit the internet and search for the same, you will be surprised just how many are there. Thank God that the advancement seen in the field of technology has brought tremendous benefits to...
![]()
Cancers that Cause Blood in the Urine (Hematuria)The presence of blood in the urine may be accompanied by pain during urination or it could also be painless. A painless hematuria may be caused by various health conditions such as cancers.Blood in the UrineThe presence of blood in the urine, may it be microscopic or gross, means something is wrong...
![]()
Are Relatives of Someone with Breast Cancer Automatically at Risk?It is only natural to be concerned as to whether there is an increased risk of cancer in your family if you or one of your close family members (mother, father, brother, sister, son, or daughter) have been diagnosed with breast cancer. This is known as a family history of cancer. However, most...
![]()
After Ovarian Cancer Diagnosis: What to ExpectNo two people are going to experience their diagnosis of ovarian cancer in the same way. Although some emotions, such as shock and grief, are common feelings among those who are newly diagnosed with cancer, not everyone will feel their emotions in the same degree or in the same order. All cancer is...
![]()
Is Cervical Cancer a Preventable Disease?Cervical cancer is probably one of the most common forms of cancer in young women. Cervical cancer is the cancer of the cervix, which connects the uterus and the vagina. The endocervix is the part of the cervix that is closest to the uterus while the ectocervix is nearer to the vagina. Most cases...
Nearby Providers
![]()
Hima Bindu Lingam2525 Cumberland Pkwy Atlanta Georgia 30339![]()
Dr. Michael Paul Fanucchi M.D.550 Peachtree St Atlanta GA 30308![]()
Dr. Ruth M O'regan MD1365 Clifton Rd Ne Atlanta GA 30322![]()
Dr. Sujana Movva MD550 Peachtree St Ne Atlanta GA 30308![]()
Dr. Navneet Dhillon M.D.1365c Clifton Rd Ne Atlanta GA 30322![]()
Dr. Suresh Sakkarai Ramalingam MD1365 Clifton Rd Ne Atlanta GA 30322
Nearest Hospitals
CHILDREN'S HEALTHCARE OF ATLANTA AT EGLESTONl
1405 CLIFTON ROAD, NE ATLANTA GA 30322EMORY UNIVERSITY HOSPITALl
1364 CLIFTON ROAD, NE ATLANTA GA 30322EMORY UNIVERSITY HOSPITALl
1364 CLIFTON ROAD, NE ATLANTA GA 30322CHILDREN'S HEALTHCARE OF ATLANTA AT EGLESTONl
1405 CLIFTON ROAD, NE ATLANTA GA 30322